1.	A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer Phase: Phase IV Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML18527, NCT00121836
2.	Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer Phase: Phase IV Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSTI571BDE28, 2005-001537-15, NCT00372476
3.	Phase II/III Randomized Study of Vinorelbine, Cisplatin, and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) Versus CHART Alone in Patients With Stage I-III Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Treatment Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: MRC-LU23, EU-20535, EU-INCH-20535, EudraCT-2004-004438-15, NCT00253591
4.	Phase III Randomized Study of Epirubicin/Vinorelbine vs Epirubicin Alone for Advanced Breast Cancer (Summary Last Modified 06/1999) Phase: Phase III Type: Treatment Status: Closed Age: 18 to 75 Sponsor: Protocol IDs: DAN-DBCG-94-03, EU-95008
5.	Phase III Randomized Study of TAX/CBDCA vs VNB/CDDP for Stage IV and Selected Stage IIIB non-Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-9509
6.	Phase III Randomized Study of High-Dose vs Low-Dose Docetaxel vs Standard Chemotherapy with Vinorelbine or Ifosfamide for Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy (Summary Last Modified 08/97) Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830
7.	Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Completed Age: 18 to 75 Sponsor: Other Protocol IDs: CDR0000065002, FRE-IALT, EU-96010, NCT00002823
8.	Phase III Randomized Study of Adjuvant Fluorouracil/Epirubicin/Cyclophosphamide vs Epirubicin/Vinorelbine in Women with High-Risk Node-Positive Breast Cancer (Summary Last Modified 09/1999) Phase: Phase III Type: Treatment Status: Closed Age: under 65 Sponsor: Protocol IDs: FRE-FNCLCC-GFEA-09, EU-96015, FRE-GFEA-09
9.	Phase III Randomized Study of Surgery With or Without Preoperative Chemotherapy in Patients With Resectable Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: Any age Sponsor: Other Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159
10.	Phase III Randomized Study of Cisplatin-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: Adult Sponsor: Protocol IDs: LLCG-BLT, MRC-BLT, EU-98003, NCT00003240
11.	Phase III Randomized Study of Vinorelbine, Gemcitabine, or Both in Elderly Patients with Stage IIIB or Stage IV Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: 70 and over Sponsor: Protocol IDs: ITA-MILES, ITA-GOCSI-MILES, EU-98019, NCT00003447
12.	Phase III Randomized Study of Docetaxel Plus Cisplatin or Docetaxel Plus Carboplatin versus Vinorelbine Plus Cisplatin in Chemotherapy-Naive Patients with Unresectable, Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: RP-56976-TAX-326, RP-56976-V-326
13.	Phase III Randomized Study of Gemcitabine Plus Vinorelbine vs Standard Chemotherapy Containing Cisplatin in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: Under 70 Sponsor: Other Protocol IDs: ITA-GEMVIN, CAN-NCIC-BR14, EU-99016, NCT00004100, BR14
14.	Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCCAM, NCI, Other Protocol IDs: NCI-2012-02725, ID99-303, U10CA045809, CDR0000067853, MDA-ID-99303, NCCAM, NCI-T99-0046, RTOG-0270, NCT00005838
15.	Phase III Randomized Study of Cisplatin and Vinorelbine With or Without Tirapazamine in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer (Summary Last Modified 04/2002). Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SANOFI-EFC3675, NCT00017459
16.	Phase III Randomized Study of Cisplatin and Vinorelbine With or Without Bexarotene in Patients With Chemotherapy-Naive Advanced or Metastatic Non-Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Closed Age: Any age Sponsor: Pharmaceutical / Industry Protocol IDs: LIGAND-L1069-49
17.	Phase III Comparison of Vinorelbine vs 5-FU/CF in Patients with Inoperable, Previously Untreated Stage IV non-Small Cell Lung Cancer (Summary Last Modified 06/91) Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: BW-P70-34972-02, NCI-V91-0069
18.	Phase III Comparison of Melphalan vs Vinorelbine in Women with Anthracycline-Resistant Breast Cancer (Summary Last Modified 05/91) Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: BW-P70-34972-01, NCI-V91-0068
19.	Phase III Randomized Study of VNB/DOX vs DOX Alone in Metastatic or Recurrent Breast Cancer (Summary Last Modified 08/95) Phase: Phase III Type: Treatment Status: Closed Age: 18 to 75 Sponsor: Protocol IDs: CAN-NCIC-MA8, NCI-V92-0010, MA8
20.	Phase III Randomized Study of CDDP vs CDDP/VNB for Previously Untreated Stage IV and Selected Stage IIIB Nonsmall Cell Lung Cancer Phase: Phase III Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: SWOG-9308
21.	Phase III Randomized Study of Polyglutamate Paclitaxel (CT-2103) Versus Gemcitabine or Vinorelbine in Patients With Stage IIIB or IV or Recurrent Non-Small Cell Lung Cancer Who Have a Performance Status of 2. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTI-PGT304, NCT00054197
22.	Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000306463, GOG-0204, NCT00064077
23.	Phase III Randomized Study of Active Symptom Control With Versus Without Chemotherapy in Patients With Malignant Pleural Mesothelioma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: BTS-MRC-MS01, ISRCTN54469112, EU-20349, NCT00075699
24.	Phase III Randomized Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: JMTO-LC00-03, NCT00079287
25.	Phase III Randomized Study of Vinorelbine With or Without Trastuzumab (Herceptin®) in Women With HER2-Positive Progressive Metastatic Breast Cancer Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0347, S0347, NCT00103233